PMID: 9531230Apr 8, 1998Paper

Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group

Archives of Internal Medicine
H K GenantJ C Nolan

Abstract

Prospective studies have shown that doses equivalent to conjugated equine estrogens of 0.625 mg/d or higher are needed to produce a significant increase in bone mineral density of the lumbar spine. To determine the effects of unopposed esterified estrogens on bone mineral density, lipid levels, and endometrial tissue structure, and to relate these effects to changes in plasma estradiol levels. Four hundred six postmenopausal women were given calcium, 1000 mg/d, and randomly assigned to receive continuous esterified estrogens (0.3, 0.625, or 1.25 mg/d) or placebo for 24 months. Bone mineral density measurements and endometrial and laboratory assessments were conducted every 6 months; plasma estradiol concentrations were measured after 12, 18, and 24 months. All doses of esterified estrogens produced significant increases in bone mineral density of the lumbar spine compared with baseline and with placebo at 6, 12, 18, and 24 months. Mean plasma estradiol levels increased with esterified estrogens dose, and individual subject bone mineral density changes appeared related to plasma estradiol concentrations. Clinically relevant rates of endometrial hyperplasia were noted only in the groups receiving 0.625 and 1.25 mg of esterified e...Continue Reading

Citations

Dec 13, 2003·Maturitas·Jos H H Thijssen
Apr 6, 2004·Maturitas·Herjan J T Coelingh Bennink
Mar 18, 2000·Archives of Physical Medicine and Rehabilitation·P A LimT H Oh
Nov 6, 1998·Disease-a-month : DM·W B Cutler, E Genovese-Stone
Feb 15, 2001·Fertility and Sterility·W R MeyerS Girdler
Aug 17, 2001·Obstetrics and Gynecology·B EttingerA Van Gessel
Dec 4, 2001·Maturitas·M Gambacciani, A R Genazzani
Jun 18, 2002·Maturitas·S GranbergL Wilhelmsson
Oct 4, 2002·Maturitas·Hermann P G Schneider
Feb 8, 2000·Maturitas·H P Schneider, J C Gallagher
Feb 8, 2000·Maturitas·F Brackman
Feb 13, 2001·The Journal of Steroid Biochemistry and Molecular Biology·L H KullerE N Meilahn
Aug 2, 2001·Journal of Midwifery & Women's Health·M E Rousseau
Dec 18, 2002·Journal of Midwifery & Women's Health·Mary Ellen Rousseau
Sep 10, 1998·The New England Journal of Medicine·L G Raisz, K M Prestwood
Dec 24, 2010·Current Opinion in Nephrology and Hypertension·Xiao-Ping Yang, Jane F Reckelhoff
Aug 14, 1998·BMJ : British Medical Journal·E Barrett-Connor
Jun 30, 2001·The Western Journal of Medicine·S Ratner, D Ofri
Jan 5, 2002·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Hassan M HeshmatiB Lawrence Riggs
Oct 3, 2002·Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry·A A KhanUNKNOWN International Society for Clinical Densitometry
Apr 1, 2003·Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry·A A KhanUNKNOWN Canadian Panel of International Society for Clinical Densitometry
Jan 23, 1999·Pharmacotherapy·M B O'Connell
Dec 21, 2000·Current Rheumatology Reports·R L WolfJ A Cauley
Nov 1, 2003·Journal of Women's Health·Carolyn Crandall
Jan 25, 2005·Journal of Women's Health·Laura S HarknessEdith Lerner
May 26, 2007·Journal of the Chinese Medical Association : JCMA·Tzay-Shing YangHeung-Tat Ng
Sep 14, 2010·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Na Young KimDooSeok Choi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.